Caxton Associates (New York)’s Innospec IOSP Stock Holding History
Bought
Maintained
Sold
Other funds holding IOSP
RA
CIP
Caxton Associates (New York)'s IOSP Position: Q1 2022 in Review
Caxton Associates (New York) sold out of Innospec (IOSP) in Q1 2022, closing a stake of 2,659 shares — an estimated $240K sold.
Caxton Associates (New York) first reported a position in IOSP in Q3 2020 and held it in 4 quarters. The position peaked at $287K in Q3 2020. 188 funds tracked by Wall St. Rank hold IOSP as of Q1 2022.
- Caxton Associates (New York) reported no remaining Innospec position as of Q1 2022 after selling out during the quarter.
- Caxton Associates (New York) sold 2,659 Innospec shares in Q1 2022, an estimated $240K.
- Caxton Associates (New York) first reported a position in Innospec in Q3 2020 and held it in 4 quarters.
- Caxton Associates (New York)'s Innospec position peaked at $287K in Q3 2020.
- 188 funds tracked by Wall St. Rank held Innospec as of Q1 2022.
Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.